BLISSGVSNSEBliss GVS Pharma Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 2 Jun, 2026 · 11:02 IST

Open offer detailed public statement filed for Bliss GVS Pharma

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDFExplain this filing

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+8.3%Reaction day
₹402.40
prior close
₹428.30
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.1%+7.2% vs market
Pharmaceuticals peers, median of 164sector-0.3%+8.6% vs sector

On the reaction day the stock moved 7.2 pts more than Nifty Microcap 250 and 8.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.9
10m
+1.5
15m
+1.4
30m
+1.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+8.3+1.1+7.2-0.3+8.6
Next day
+9.2+1.3+7.8-0.4+9.5
2d
+12.7+2.2+10.5-0.4+13.0
3d
+8.8+2.2+6.6+0.2+8.6
4d
+4.7+0.2+4.6-0.7+5.5
5d
+4.7+2.1+2.6+0.4+4.3
1w
+8.8-0.5+9.4-0.5+9.4
15d
+16.7+7.5+9.2+4.4+12.2
1m
+30.6+8.6+22.0+5.7+24.9
2m
+15.1+9.1+6.0+6.3+8.8
3m
+60.3+11.8+48.6+7.3+53.0
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Manager SBI Capital Markets has filed a Detailed Public Statement with NSE for an open offer to public shareholders of Bliss GVS Pharma under SEBI Takeover Regulations 2011. Filing made under regulations covering substantial acquisition of shares. The detailed statement will contain offer price, share quantity, and timeline. Public shareholders should review the offer document for exit opportunity.

Likely market impact

Shareholders can review the detailed public statement for offer price and tendering details. May create short-term price volatility.